The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review
Open accessAbstract
Objective: To summarise the findings of an updated Cochrane review of interventions aimed at improving the appropriate use of polypharmacy in older people. Design: Cochrane systematic review. Multiple electronic databases were searched including MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials (from inception to November 2013). Hand searching of references was also performed. Randomised controlled trials (RCTs), controlled clinical trials, controlled before-and-after studies and interrupted time series analyses reporting on interventions targeting appropriate polypharmacy in older people in any healthcare setting were included if they used a validated measure of prescribing appropriateness. Evidence quality was assessed using the Cochrane risk of bias tool and GRADE (Grades of Recommendation, Assessment, Development and Evaluation). Setting: All healthcare settings. Participants: Older people (≥65 years) with ≥1 long-term condition who were receiving polypharmacy (≥4 regular medicines). Primary and secondary outcome measures: Primary outcomes were the change in prevalence of appropriate polypharmacy and hospital admissions. Medication-related problems (eg, adverse drug reactions), medication adherence and quality of life were included as secondary outcomes. Results: 12 studies were included: 8 RCTs, 2 cluster RCTs and 2 controlled before-and-after studies. 1 study involved computerised decision support and 11 comprised pharmaceutical care approaches across various settings. Appropriateness was measured using validated tools, including the Medication Appropriateness Index, Beers’ criteria and Screening Tool of Older Person's Prescriptions (STOPP)/ Screening Tool to Alert doctors to Right Treatment (START). The interventions demonstrated a reduction in inappropriate prescribing. Evidence of effect on hospital admissions and medication-related problems was conflicting. No differences in health-related quality of life were reported. Conclusions: The included interventions demonstrated improvements in appropriate polypharmacy based on reductions in inappropriate prescribing. However, it remains unclear if interventions resulted in clinically significant improvements (eg, in terms of hospital admissions). Future intervention studies would benefit from available guidance on intervention development, evaluation and reporting to facilitate replication in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Developing and evaluating complex interventions: the new Medical Research Council guidance
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008) · BMJ · doi:10.1136/bmj.a1655 · Cited by 10,995
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
(2008) · Cited by 3,790
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Opportunities and responsibilities in pharmaceutical care
Hepler, C. D., & Strand, L. M. (1990) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/47.3.533 · Cited by 2,895
Implementation strategies: recommendations for specifying and reporting
Proctor, E. K., Powell, B. J., & McMillen, J. C. (2013) · Implementation Science · doi:10.1186/1748-5908-8-139 · Cited by 2,585 · cited 1×
“47 48 Future studies should use clearer de fi nitions of appropriate polypharmacy because the term ‘ polypharmacy ’ can be both negative and positive, and this duality of meaning makes objective research dif fi cult.”
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Developing and Evaluating Complex Interventions: New Guidance
Craig, P., Dieppe, P. A., MacIntyre, S., Michie, S., Nazareth, I., & Petticrew, M. P. (2006) · UCL Discovery (University College London) · Cited by 1,974
Clinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,938
Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & OMahony, D. (2008) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46072 · Cited by 1,506
Self-citationPolypharmacy in elderly patients
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.12.002 · Cited by 1,265
Appropriate prescribing in elderly people: how well can it be measured and optimised?
Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61091-5 · Cited by 1,090
Self-citationA method for assessing drug therapy appropriateness☆
Hanlon, J. T., Schmader, K. E., Samsa, G. P., Weinberger, M., Uttech, K. M., Lewis, I. K., Cohen, H. J., & Feussner, J. R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90144-c · Cited by 960
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Self-citationHanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., Cowper, P. A., Landsman, P. B., Cohen, H. J., & Feussner, J. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89519-8 · Cited by 612
Rechel, B., Grundy, E., Robine, J.-M., Cylus, J., Mackenbach, J. P., Knai, C., & McKee, M. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62087-x · Cited by 592
Gallagher, P. F., O'Connor, M. N., & O'Mahony, D. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.44 · Cited by 505
Polypharmacy: Misleading, but manageable
Bushardt, R. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2468 · Cited by 489
Defining inappropriate practices in prescribing for elderly people: a national consensus panel.
McLeod, P. J., Huang, A. R., Tamblyn, R. M., & Gayton, D. (1997) · Europe PMC (PubMed Central) · Cited by 486
Cahir, C., Fahey, T., Teeling, M., Teljeur, C., Feely, J., & Bennett, K. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03628.x · Cited by 418
Hill-Taylor, B., Sketris, I., Hayden, J., Byrne, S., O'Sullivan, D., & Christie, R. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12059 · Cited by 369
Holland, R., Desborough, J., Goodyer, L., Hall, S., Wright, D., & Loke, Y. K. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03071.x · Cited by 365
Reduction of Polypharmacy in the Elderly: A Systematic Review of the Role of the Pharmacist
Rollason, V., & Vogt, N. (2003) · Drugs & Aging · doi:10.2165/00002512-200320110-00003 · Cited by 361
Schmader, K. E., Hanlon, J. T., Pieper, C. F., Sloane, R., Ruby, C. M., Twersky, J., Francis, S. D., Branch, L. G., Lindblad, C. I., Artz, M., et al. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.031 · Cited by 334
Crotty, M., Rowett, D., Spurling, L., Giles, L. C., & Phillips, P. A. (2004) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2005.01.001 · Cited by 308
Spinewine, A., Swine, C., Dhillon, S., Lambert, P., Nachega, J. B., Wilmotte, L., & Tulkens, P. M. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01132.x · Cited by 307
Interventions to optimise prescribing for older people in care homes
Alldred, D. P., Kennedy, M.-C., Hughes, C., Chen, T. F., & Miller, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009095.pub3 · Cited by 303
Self-citationMichie, S., Abraham, C., Eccles, M. P., Francis, J. J., Hardeman, W., & Johnston, M. (2011) · Implementation Science · doi:10.1186/1748-5908-6-10 · Cited by 301
Tamblyn, R. M., Huang, A. R., Perreault, R. B., Jacques, A., Roy, D., Hanley, J. A., McLeod, P. J., & Laprise, R. (2003) · Europe PMC (PubMed Central) · Cited by 291
Interventions that can Reduce Inappropriate Prescribing in the Elderly: A Systematic Review
Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009) · Drugs & Aging · doi:10.2165/11318890-000000000-00000 · Cited by 290
Ryan, R. E., Santesso, N., Lowe, D., Hill, S., Grimshaw, J. M., Prictor, M., Kaufman, C., Cowie, G., & Taylor, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007768.pub3 · Cited by 273
Relationship between polypharmacy and underprescribing
Kuijpers, M. A. J., Van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., & The OLDY (OLd people Drugs & dYsregulations) study group (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02961.x · Cited by 253
Inappropriate prescribing: a systematic overview of published assessment tools
Kaufmann, C. P., Tremp, R., Hersberger, K. E., & Lampert, M. L. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1575-8 · Cited by 246
Crotty, M. (2004) · Age and Ageing · doi:10.1093/ageing/afh213 · Cited by 209
Dimitrow, M. S., Airaksinen, M. S. A., Kivelä, S., Lyles, A., & Leikola, S. N. S. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03497.x · Cited by 203
Bradley, M. C., Fahey, T., Cahir, C., Bennett, K., O’Reilly, D., Parsons, C., & Hughes, C. M. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1249-y · Cited by 177
Self-citationDalleur, O., Boland, B. B., Losseau, C., Henrard, S., Wouters, D., Speybroeck, N., Degryse, J., & Spinewine, A. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0157-5 · Cited by 158
Improving primary care in rural Alabama with a pharmacy initiative
Taylor, C. T., Byrd, D. C., & Krueger, K. P. (2003) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/60.11.1123 · Cited by 138
Underprescription of Beneficial Medicines in Older People: Causes, Consequences and Prevention
Cherubini, A., Corsonello, A., & Lattanzio, F. (2012) · Drugs & Aging · doi:10.2165/11631750-000000000-00000 · Cited by 129
Interventions to optimise prescribing for older people in care homes
Alldred, D. P., Raynor, D. K., Hughes, C. M., Barber, N., Chen, T. F., & Spoor, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009095.pub2 · Cited by 118
Self-citationAronson, J. K. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02067.x · Cited by 89
Cahir, C., Moriarty, F., Teljeur, C., Fahey, T. P., & Bennett, K. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014552821 · Cited by 67
Polypharmacy and the Balance of Medication Benefits and Risks
Steinman, M. A. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.12.009 · Cited by 52
Trygstad, T. K., Christensen, D. B., Wegner, S., Sullivan, R., & Garmise, J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.09.006 · Cited by 38
Interventions to optimize prescribing for older people in care homes. (Protocol).
Alldred, D. P., Raynor, D. K., Hughes, C. M., Barber, N., Chen, T.-J., & Spoor, P. (2011) · Research Portal (Queen's University Belfast) · Cited by 34
Self-citation
Cited by
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Morin, L., Johnell, K., Laroche, M.-L., Fastbom, J., & Wastesson, J. W. (2018) · Clinical Epidemiology · doi:10.2147/clep.s153458 · Cited by 376
Association between polypharmacy and death: A systematic review and meta-analysis
Leelakanok, N., Holcombe, A. L., Lund, B. C., Gu, X., & Schweizer, M. L. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.06.002 · Cited by 355
Reeve, E., Thompson, W., & Farrell, B. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.12.021 · Cited by 331
Polypharmacy and Medication Management in Older Adults
Kim, J., & Parish, A. L. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.04.007 · Cited by 245
Metadata
- Authors
- Cooper, J. A., Cadogan, C. A., Patterson, S. M., Kerse, N., Bradley, M. C., Ryan, C., & Hughes, C. M.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2015-12
- Volume
- 5
- Issue
- 12
- Pages
- e009235
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2225022024
- Cited by
- 344
- References
- 46
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.